David Flynn, J.D.Senior Director of Legal and Regulatory Affairs at Olympia PharmaceuticalsSpeaker
Agenda Sessions
Informa Connect Welcome and Chair’s Opening Remarks
, 8:45amView SessionLegal Spotlight – FDA’s Removal of Tirzepatide from the Drug Shortage List
, 9:45amView SessionChair’s Closing Remarks and Close of Conference
, 3:00pmView Session